CAS: 314-13-6; Sodium 6,6'-((3,3'-Dimethyl-[1,1'-Biphenyl]-4,4'-Diyl)Bis(Diazene-2,1-Diyl))Bis(4-Amino-5-Hydroxynaphthalene-1,3-Disulfonate)

该化合物是生物医学研究中常用的 Diazo 染色物,因为它能与血清相册结合,使其成为研究血管透视能力,等离子体体体积测量和血液脑屏障完整性的宝贵工具.它与相簿的高度亲近性能确保了最小地扩散到间空间,对血管功能的准确评估.染色剂还被用于染色组织血迹学和药用动能研究中,以跟踪蛋白的分布.埃文斯蓝体是水溶性,在可见光谱中表现出很强的吸收力,通过光谱测量促进定量分析.它的稳定性和可复制性使得它成为实验和诊断应用的可靠选择.

结构式图片

欧盟法规

《欧盟PIC法规》ECHA物质ECHA物质OtherC&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-6201168-B1
    优先权日:1999-08-20
    标题:Pathogenesis of cardiomyopathy
    发明人:CAMPBELL KEVIN P; CORAL RAMON; COHN RONALD; WILLIAMSON ROGER; DURBEEJ MADELEINE
    权利人:UNIV IOWA RES FOUND
    摘要:Disclosed is a mouse, cells derived therefrom, and methods for using the mouse, the mouse being homozygous for a disrupted δ-sarcoglycan gene, the disruption in the gene having been introduced into the mouse or an ancestor of the mouse at an embryonic stage. The disruption prevents the synthesis of functional δ-sarcoglycan in cells of the mouse and results in the mouse having a reduced amount of β- and ε-sarcoglycan and sarcospan, and a disruption of the sarcoglycan-sarcospan complex in smooth muscle of the mouse. Also disclosed is a mouse, cells derived therefrom, and methods for using the mouse, the mouse being homozygous for a disrupted β-sarcoglycan gene, the disruption in the gene having been introduced into the mouse or an ancestor of the mouse at an embryonic stage. The disruption prevents the synthesis of functional β-sarcoglycan in cells of the mouse and results in the mouse having a reduced amount of δ-and ε-sarcoglycan and sarcospan and α-dystroglycan in smooth muscle of the mouse.

    专利号:WO-9619572-A1
    优先权日:1994-12-22
    标 题:Synthesis of stereospecific oligonucleotide phosphorothioates
    发明人:TANG JINYAN; ROSKEY ALLYSEN M; AGRAWAL SUDHIR
    权利人:HYBRIDON INC; TANG JINYAN; ROSKEY ALLYSEN M; AGRAWAL SUDHIR
    摘要:Disclosed is a method for synthesizing of stereospecific (Rp) phosphorothioate oligonucleotides. In this method, a primer comprising a plurality of deoxyribonucleotides and a ribonucleotide at the 5' terminal or 5' penultimate position, is annealed to a template. The structure is contacted with a mixture of deoxynucleoside α-triphosphate Sp diastereomers and a DNA polymerase to form a PS-Rp oligodeoxynucleotide extension which is liberated as a single-stranded PS-Rp oligonucleotide by cleavage after the ribonucleotide in the primer. Also disclosed are PS-Rp oligonucleotides and oligonucleotides prepared according to this method.

    专利号:WO-9700244-A1
    优先权日:1995-06-19
    标题 :Process for parallel synthesis of a non-peptide library
    发明人:FRITZ JAMES E; KALDOR STEPHEN W
    权利人:LILLY CO ELI; FRITZ JAMES E; KALDOR STEPHEN W
    摘要:A process for the sequential preparation of a library of compounds having pharmaceutical usage. The process involves the sequential mixing of solution phase reagents, followed by scavenging of excess unreacted reagents with solid phase scavenging agents. The process is highly iterative and applicable for producing various ureas, thiureas, amides, carbonates and tertiary amines.

    专利号:US-10849901-B2
    优先权日:2014-05-27
    标题 :Arf6 inhibitors and methods of synthesis and use thereof
    发明人:OSTANIN KIRILL; SHENDEROVICH MARK; BAJJI ASHOK; CIOFFI CHRISTOPHER L; MOSS NEIL; VANKAYALAPATI HARIPRASAD; LI DEAN
    权利人:NAVIGEN INC; THE UNIV OF UTAH RESEARCH FOUNCATION; THE UNIV OF UTAH RESEARCH FOUNDATION
    摘要:Disclosed herein are compounds and methods for inhibiting Arf6. Pharmaceutical compositions and methods for treating a subject with an inhibitor of Arf6 are also disclosed herein.

    专利号:US-5876962-A
    优先权日:1987-08-12
    标题:Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors
    发明人:BISHOP DAVID H L; EMERY VINCENT CLIVE
    权利人:NATURAL ENVIRONMENT RES
    摘要:Expression vectors for the expression of proteins, particularly eukaryotic proteins are provided which are based on novel plasmid replicons. Sequence cassettes useful in constructing such vectors are also disclosed. The expression vectors according to the invention are useful for expressing selected proteins in insects and insect cells. Specifically, the plasmid replicons comprise double-stranded DNA having (a) one or more sequences allowing the replicon to be reproduced in a bacterial host, (b) first and second sequences which are adapted to permit an intervening sequence located between said first and second sequences to be introduced into an expression vector, and (c) an intervening sequence located between said first and second sequences, and are characterised in that the intervening sequence comprises first and second polypeptide expression sequences (PESs) wherein each PES includes (i) a transcriptional promotor (ii) a unique restriction site for introduction of a gene which is native or foreign to the expression vector and (iii) a transcriptional termination site.

    专利号:EP-0327626-B1
    优先权日:1987-08-12
    标 题:Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors
    摘要:Expression vectors for the expression of proteins, particularly eukaryotic proteins are provided which are based on novel plasmid replicons. Sequence cassettes useful in constructing such vectors are also disclosed. The expression vectors according to the invention are useful for expressing selected proteins in insects and insect cells. Specifically, the plasmid replicons comprise double-stranded DNA having (a) one or more sequences allowing the replicon to be reproduced in a bacterial host, (b) first and second sequences which are adapted to permit an intervening sequence located between said first and second sequences to be introduced into an expression vector, and (c) an intervening sequence located between said first and second sequences, and are characterised in that the intervening sequence comprises first and second polypeptide expression sequences (PESs) wherein each PES includes (i) a transcriptional promotor (ii) a unique restriction site for introduction of a gene which is native or foreign to the expression vector and (iii) a transcriptional termination site.
    湖南汇百益新材料有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hbsjxcl.com/
    电话: 133-0845-3923 13319523173👤
    📞湖南汇百益新材料有限公司 ⚠️参考联系方式

    销售电话:133-0845-3923 13319523173
    邮箱:ivy@hnhbsj.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm701302v
    摘要:Auld DS, Southall NT, Jadhav A, Johnson RL, Diller DJ, Simeonov A, Austin CP, Inglese J. Characterization of chemical libraries for luciferase inhibitory activity. J Med Chem. 2008 Apr 24;51(8):2372–86. doi: 10.1021/jm701302v.
    参考文献:10.1021/acs.jmedchem.0c01044
    摘要:Jeffrey JL, Lawson KV, Powers JP. Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39. J Med Chem. 2020 Nov 25;63(22):13444–65. doi: 10.1021/acs.jmedchem.0c01044.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知